Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Moy

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 31, 2025
Development and refinement of a nurse-led, culturally sensitive intervention for adjuvant endocrine therapy initiation among patients with breast cancerKathryn E Post, Laura Dunderdale, Shibani Datta, et al.
Biomedical Optics Express|January 11, 2014
Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography systemStefan A Carp, Amir Y Sajjadi, Christy M Wanyo, et al.
Therapeutic Advances in Medical Oncology|December 22, 2025
Current landscape of sequencing ADCs in metastatic breast cancerShannon McLaughlin, Lis V Ravani, Beverly Moy, et al.
NPJ Breast Cancer|March 12, 2025
Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsiesYael Bar, Geoffrey Fell, Aylin Dedeoglu, et al.
Breast Cancer Research and Treatment|February 13, 2016
Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centersInes Vaz-Luis, Melissa E Hughes, Angel Cronin, et al.
Breast Cancer Research and Treatment|April 27, 2023
Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study)Steven J Isakoff, Maya R Said, Agnes H Kwak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2023
ASCO Ethical Guidance for the Practical Management of Oncology Drug ShortagesAndrew Hantel, Rebecca Spence, Polo Camacho, et al.
The Oncologist|March 29, 2014
Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancerBeverly Moy, Patrick Neven, Fabienne Lebrun, et al.
Cancer|March 12, 2015
Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional studyInes Vaz-Luis, Melissa E Hughes, Angel M Cronin, et al.
The Oncologist|March 29, 2014
Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancerBeverly Moy, Patrick Neven, Fabienne Lebrun, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 31, 2025
Development and refinement of a nurse-led, culturally sensitive intervention for adjuvant endocrine therapy initiation among patients with breast cancerKathryn E Post, Laura Dunderdale, Shibani Datta, et al.
Biomedical Optics Express|January 11, 2014
Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography systemStefan A Carp, Amir Y Sajjadi, Christy M Wanyo, et al.
Therapeutic Advances in Medical Oncology|December 22, 2025
Current landscape of sequencing ADCs in metastatic breast cancerShannon McLaughlin, Lis V Ravani, Beverly Moy, et al.
NPJ Breast Cancer|March 12, 2025
Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsiesYael Bar, Geoffrey Fell, Aylin Dedeoglu, et al.
Breast Cancer Research and Treatment|February 13, 2016
Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centersInes Vaz-Luis, Melissa E Hughes, Angel Cronin, et al.
Breast Cancer Research and Treatment|April 27, 2023
Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study)Steven J Isakoff, Maya R Said, Agnes H Kwak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2023
ASCO Ethical Guidance for the Practical Management of Oncology Drug ShortagesAndrew Hantel, Rebecca Spence, Polo Camacho, et al.
The Oncologist|March 29, 2014
Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancerBeverly Moy, Patrick Neven, Fabienne Lebrun, et al.
Cancer|March 12, 2015
Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional studyInes Vaz-Luis, Melissa E Hughes, Angel M Cronin, et al.
The Oncologist|March 29, 2014
Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancerBeverly Moy, Patrick Neven, Fabienne Lebrun, et al.
Pageof 17